DOM Newsletter (June 24)
April 14, 2020
News
Progression of inflammatory lung disease analyzed
April 01, 2020
A Vanderbilt University Medical Center interim analysis shows that there appears to be a considerable length of time before a subset of people develop inflammatory, scarring lung diseases where there is radiologically detectable evidence they will develop lung disease.
Questions and answers on epidemiology of COVID-19
March 26, 2020
Though he specializes in chronic disease, epidemiologist Qi Dai, MD, PhD, professor of Medicine, has been closely following the international scientific literature on SARS-CoV-2 and the disease it causes, COVID-19 (coronavirus disease 2019). He answered questions on March 19, when total U.S.
Study reveals an inherited origin of prostate cancer in families
March 26, 2020
Vanderbilt researchers have identified haplotypes, ancestral fragments of DNA, that are associated with hereditary prostate cancer (HPC) in a first-of-its-kind genomic study made possible by the study of prostate cancer patients with family histories of the disease.
Race, hormones and diabetes risk
March 20, 2020
Natriuretic peptides (NP) are hormones released from the heart that reduce blood pressure, insulin resistance and body fat accumulation.
Meat intake and colorectal polyps
March 20, 2020
Conventional colorectal adenomas are the precursor lesions for most colorectal cancers. In addition to these adenomas, other colorectal polyps are detected during colonoscopy.
One-two punch for cancer
March 05, 2020
Many cancer cells evade critical DNA surveillance and maintenance by increasing the export — by the Exportin-1 (XPO1) nucleo-cytoplasmic transport protein — of nearly all major tumor suppressor proteins from the nucleus.
Study finds certain genetic test not useful in predicting heart disease risk
February 27, 2020
A Polygenic Risk Score — a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients — has been found not to be a useful predictive biomarker for disease risk, according to a Vanderbilt study published in the Journal of the American Medical Association.
Potential new heartburn drug studied at VUMC
February 27, 2020
An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.